Cargando…
Standard care informed by the result of a placental growth factor blood test versus standard care alone in women with reduced fetal movement at or after 36(+0) weeks’ gestation: a pilot randomised controlled trial
BACKGROUND: Biomarkers of placental function can potentially aid the diagnosis and prediction of pregnancy complications. This randomised controlled pilot trial assessed whether for women with reduced fetal movement (RFM), intervention directed by the measurement of a placental biomarker in addition...
Autores principales: | Armstrong-Buisseret, Lindsay, Godolphin, Peter J., Bradshaw, Lucy, Mitchell, Eleanor, Ratcliffe, Sam, Storey, Claire, Heazell, Alexander E. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020549/ https://www.ncbi.nlm.nih.gov/pubmed/32082609 http://dx.doi.org/10.1186/s40814-020-0561-z |
Ejemplares similares
-
Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36(+ 0) weeks gestation
por: Armstrong-Buisseret, Lindsay, et al.
Publicado: (2018) -
A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study
por: Heazell, Alexander EP, et al.
Publicado: (2013) -
Cord pilot trial, comparing alternative policies for timing of cord clamping before 32 weeks gestation: follow-up for women up to one year
por: Bradshaw, Lucy, et al.
Publicado: (2019) -
The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32 + 0 weeks’ gestation
por: Gent, Joanna, et al.
Publicado: (2020) -
Benign Recurrent Intrahepatic Cholestasis in Pregnancy: Fetal Death at 36 Weeks of Gestation
por: Ayyash, Mariam, et al.
Publicado: (2021)